Moravek Biochemicals, Inc.
- Company typePrivate
- Founded1975
- HeadquartersBrea, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Moravek Biochemicals, Inc. firmographics
Firmographics- Name
- Moravek Biochemicals, Inc.
- Legal name
- Moravek, Inc.
- Website
- https://moravek.com
- Company type
- Private
- Founded year
- 1975
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Moravek Biochemicals, Inc. industry classification
Industry- Product category
- Radiolabeled Compound Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- Radiopharmaceutical CDMO & Manufacturing (GMP Fill-Finish) (HLAIAGAF), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where Moravek Biochemicals, Inc. is headquartered
LocationHeadquarters
- HQ city
- Brea
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Moravek Biochemicals, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Infrastructure, Supply Chain, Operations
Revenue model
- GMP Carbon-14 Labeled API Manufacturing: Custom GMP manufacturing of carbon-14 labeled APIs for early phase clinical trials. Revenue generated through project-based contracts with pharmaceutical companies. Includes familiarization work, GMP production, quality control, and release documentation.
- Custom Non-GMP Radiolabeled Compounds: Custom synthesis of non-GMP radiolabeled compounds (carbon-14 and tritium) and stable-labeled compounds (carbon-13, deuterium, nitrogen-15) for non-clinical research.
- Catalog Products: Extensive catalog of non-GLP radiolabeled, stable-labeled, and non-labeled compounds including nucleosides, nucleotides, amino acids, antivirals, and anticancer compounds. Direct purchase of in-stock items.
- Analytical Services: HPLC/UHPLC method transfer, release testing, stability studies, and various analytical testing services for GMP and non-GMP compounds.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Tritium-labeled catalog compound: [5-³H(N)](-)-ß-L-2',3'-Dideoxy-3'-thiacytidine |
| Unit Pricing | Pay-as-you-go | Tritium-labeled catalog compound: [3',5',7-³H(N)]Methotrexate, disodium salt |
| Unit Pricing | Pay-as-you-go | Carbon-14 labeled catalog compound: [cytosine-2-¹⁴C]HPMPC |
| Unit Pricing | Pay-as-you-go | Carbon-14 labeled catalog compound: [6-¹⁴C]5-Fluorouracil |
| Unit Pricing | Pay-as-you-go | Carbon-14 labeled catalog compound: [ring-¹⁴C(U)]Acetaminophen |
| Unit Pricing | Pay-as-you-go | Stable isotope labeled catalog compound: [uracil-¹³C₁, ¹⁵N₂]Fialuridine |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Moravek Biochemicals, Inc. product offering
Product offeringCore offering
Moravek Biochemicals, Inc. is a contract development and manufacturing organization (CDMO) that specializes in the custom synthesis of radiolabeled (carbon-14 and tritium) and stable isotope-labeled (carbon-13, deuterium, nitrogen-15) compounds. The company manufactures GMP-grade carbon-14 labeled active pharmaceutical ingredients (APIs) for early phase clinical trials in ISO Class 7 cleanrooms, alongside non-GMP custom synthesis and an online catalog of off-the-shelf labeled and non-labeled compounds. Supporting offerings include analytical services (HPLC, NMR, MS), GMP stability studies, quality control/assurance, and long-term temperature-controlled storage.
Product overview
Moravek Biochemicals, Inc. is a contract development and manufacturing organization (CDMO) offering a comprehensive portfolio of labeled compound products and services. The company provides three quality levels: GMP grade (for early phase clinical trials), GLP grade, and Non-GLP grade. Core products include GMP Carbon-14 Labeled APIs, custom Carbon-14 and Tritium-Labeled Compounds, Stable-Labeled Compounds (carbon-13, deuterium, nitrogen-15), and Non-Labeled Compounds. The company also maintains an extensive catalog of off-the-shelf radiolabeled, stable-labeled, and non-labeled compounds. Supporting services include Analytical Services (HPLC/UHPLC, NMR, Mass Spectrometry), GMP Stability Studies, Quality Control, Quality Assurance, and Long-Term Storage Services. All GMP products are manufactured in ISO Class 7 cleanrooms under FDA guidance ICH Q7 Section 19.
Differentiator
Problem solved
Functional benefit
Products and services
- GMP Carbon-14 Labeled APIs Custom synthesis, purification, analysis, and release of GMP carbon-14 labeled active pharmaceutical ingredients for Phase 0 and Phase 1 clinical trials, manufactured in ISO Class 7 cleanrooms under FDA guidance ICH Q7 Section 19 for pharmaceutical companies and research institutions.
- Carbon-14 Labeled Compounds (Non-GMP Custom) Custom non-GMP manufacturing of carbon-14 labeled compounds for research purposes, including synthesis and HPLC purification, used for non-clinical drug metabolism, ADME, and tracer studies by pharmaceutical and academic researchers.
- Tritium-Labeled Compounds Custom manufacturing of tritium (hydrogen-3) labeled compounds for non-clinical research, available in generally labeled, nominally labeled, or exactly labeled forms for drug metabolism and receptor binding studies.
- Stable-Labeled Compounds Custom synthesis of stable isotope-labeled compounds using carbon-13, deuterium, and nitrogen-15 for clinical and non-clinical research applications such as LC-MS/MS internal standards and metabolism studies.
- Non-Labeled Compounds Small-scale custom manufacturing of non-labeled compounds in milligram to gram quantities for non-clinical research, with purification and analytical characterization by Moravek's chemists.
- Catalog Compounds Extensive online catalog of non-GLP radiolabeled, stable-labeled, and non-labeled compounds — including nucleosides, nucleotides, amino acids, antivirals, and anticancer compounds — available for direct purchase with 1–2 business day shipping on in-stock items.
- HPLC & UHPLC Analytical Services High-performance liquid chromatography analysis for radiochemical, chemical, and chiral purity determination, plus HPLC/UHPLC method transfer services compliant with USP <1224> for pharmaceutical clients.
- NMR Spectroscopy Services Nuclear magnetic resonance spectroscopy using 300 MHz and 400 MHz instruments for compound identification and structural confirmation; the 400 MHz NMR is qualified for GLP and GMP use covering 1H, 13C, 31P and additional nuclides.
- Mass Spectrometry (MS) Services Mass spectrometry for identification and molar activity determination, including direct injection, LC-MS, and GC-MS capabilities for radiolabeled and stable-labeled compounds.
- GMP Stability Studies Stability studies for GMP APIs with secure storage in temperature-controlled chambers (+25°C/60% RH, +4°C, -20°C, -80°C) monitored 24/7, supporting pharmaceutical shelf-life and storage condition studies.
- GMP Quality Control Services GMP release testing and analytical method transfer services compliant with USP <1224>, including limited and expanded partial revalidation options for pharmaceutical QA programs.
- GMP Quality Assurance Services Independent QA oversight for all GMP manufacturing, including SOPs, master batch records, release specifications, and Certificate of Analysis generation, ensuring regulatory compliance for clinical trial material release.
- GMP Long-Term Storage Services Secure long-term storage of GMP compounds at controlled temperatures with continuous monitoring via Rees Scientific Environmental Monitoring System (21 CFR Part 11 compliant) and backup power from a 500-kW Cummins generator with approximately 4 days of fuel.
Quantifiable outcome
- 99% custom synthesis success rate
- +4 more outcomes
Companies that use Moravek Biochemicals, Inc.
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Moravek Biochemicals, Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Moravek Biochemicals, Inc. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- National Institutes of Health (NIH)coreMoravek developed many labeled compounds in cooperation with the National Institutes of Health. Since 1980, hundreds of labeled compounds have been synthesized and made available to support a broad range of medicinal studies at leading universities and pharmaceutical companies. NIH has continued to be a valued partner for research collaborations.
Scale indicators9 records
Recent moves14 records
Expansion highlights4 records
Moravek Biochemicals, Inc. competitors and assessment
Company assessmentBroad incumbents
- Curium Pharma: Curium is a global radiopharmaceutical manufacturer and CDMO producing diagnostic and therapeutic radiopharmaceuticals. While focused on finished PET/SPECT and therapeutic products, it operates in the adjacent radiopharmaceutical manufacturing space and shares regulatory complexity with Moravek.
- Pharmaron: Pharmaron is a global CRO/CDMO with radiochemistry capabilities and radiolabeled synthesis services alongside broad drug discovery and CMC offerings. It competes with Moravek on custom radiosynthesis projects from a much larger scale and broader service portfolio.
- Revvity (formerly PerkinElmer): Revvity provides radiolabeled and stable isotope-labeled compounds, reagents, and analytical services for life sciences through its Applied Sciences and Life Sciences businesses. It is a broader incumbent with overlapping catalog and custom radiosynthesis offerings.
- Curia (formerly Albany Molecular Research): Curia is a large-scale CDMO providing API manufacturing, drug product development, and analytical services with some radiolabeled compound capabilities. It competes as a broader, scaled alternative to Moravek's CDMO offering.
- Sigma-Aldrich (Merck KGaA, Life Science): Sigma-Aldrich (part of Merck KGaA Life Science) supplies an extensive catalog of stable isotope-labeled and some radiolabeled compounds globally. It is a broad incumbent that competes with Moravek's catalog business through scale and distribution reach.
- Evotec (including Aptuit): Evotec operates integrated drug discovery and CDMO services including API manufacturing and radiolabeling through its Aptuit platform. It serves as a scaled, integrated alternative to Moravek for sponsor radiochemistry needs.
Emerging players
- Selvita S.A. Selvita is a CRO/CDMO offering drug discovery, medicinal chemistry, and custom synthesis services with growing API manufacturing capabilities. It is an emerging peer expanding into custom radiolabeled and labeled compound services comparable to Moravek's chemistry portfolio.
Direct peers
- Quotient Sciences: Quotient Sciences is a CDMO offering integrated drug development, manufacturing, and clinical pharmacology services, including 14C-labeled API manufacturing for human ADME studies. It directly competes with Moravek on GMP radiolabeled APIs for early-phase trials.
- American Radiolabeled Chemicals, Inc. (ARC): ARC is a St. Louis-based manufacturer of radiolabeled compounds (carbon-14, tritium) and stable-labeled compounds for research and pharmaceutical use. It is the closest direct competitor to Moravek in custom radiosynthesis and catalog radiolabeled products.
- ViTrax Analytical Services: ViTrax is a California-based custom radiochemical synthesis provider offering 14C and 3H labeled compounds for research and pharmaceutical use. It is a regional direct peer competing on custom radiosynthesis in a similar California footprint.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Moravek Biochemicals, Inc. social profiles
Digital presenceMoravek Biochemicals, Inc. compliance and trust
Trust signalCompliance6 records
Moravek Biochemicals, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Moravek Biochemicals, Inc. leadership team
Management profileNumber of profiles
Profiles7 records
Moravek Biochemicals, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Moravek Biochemicals, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Moravek Biochemicals, Inc.
What does Moravek Biochemicals, Inc. do?
Moravek Biochemicals, Inc. is a contract development and manufacturing organization (CDMO) that specializes in the custom synthesis of radiolabeled (carbon-14 and tritium) and stable isotope-labeled (carbon-13, deuterium, nitrogen-15) compounds. The company manufactures GMP-grade carbon-14 labeled active pharmaceutical ingredients (APIs) for early phase clinical trials in ISO Class 7 cleanrooms, alongside non-GMP custom synthesis and an online catalog of off-the-shelf labeled and non-labeled compounds. Supporting offerings include analytical services (HPLC, NMR, MS), GMP stability studies, quality control/assurance, and long-term temperature-controlled storage.
Is Moravek Biochemicals, Inc. a public or private company?
Moravek Biochemicals, Inc. is a private company. It is classified as family owned and is currently operating.
When was Moravek Biochemicals, Inc. founded?
Moravek Biochemicals, Inc. was founded in 1975. It employs 11 to 50 people.
Where is Moravek Biochemicals, Inc. based?
Moravek Biochemicals, Inc. is headquartered in Brea, United States, in the North America region.
How does Moravek Biochemicals, Inc. make money?
Four revenue lines are on record. GMP Carbon-14 Labeled API Manufacturing is the primary driver. The others are custom Non-GMP Radiolabeled Compounds, catalog Products and analytical Services.
Who are Moravek Biochemicals, Inc.'s main competitors?
Broad incumbents on record are Curium Pharma, Pharmaron, Revvity (formerly PerkinElmer), Curia (formerly Albany Molecular Research), Sigma-Aldrich (Merck KGaA, Life Science) and Evotec (including Aptuit). Selvita S.A. is listed as an emerging player. Direct peers are Quotient Sciences, American Radiolabeled Chemicals, Inc. (ARC) and ViTrax Analytical Services.
Does Moravek Biochemicals, Inc. have an API?
No public API is recorded for Moravek Biochemicals, Inc..
What industry is Moravek Biochemicals, Inc. in?
Moravek Biochemicals, Inc.'s product category is Radiolabeled Compound Contract Manufacturing. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAIAGAF, Radiopharmaceutical CDMO & Manufacturing (GMP Fill-Finish). Its NAICS code is 325412 and its SIC code is 2834.